media & press2020-11-11T10:38:31+01:00

MEDIA & PRESS

Our press kit containing the most detailed and updated information is available for download. Also available is a selection of documents and articles on the history, development and activities related to the PSE of Biasca industrial area.

HAS Healthcare Advanced Synthesis Celebrates 40 Years with the Inauguration of a New Laboratory.

HAS Healthcare Advanced Synthesis Celebrates 40 Years with the Inauguration of a New Cutting-Edge Quality Control Laboratory Center at its Manufacturing Plant in Biasca. Significant new investments for HAS Healthcare Advanced Synthesis driven by expanding demand for the development and analyses of traditional and anticancer molecules, and to support the future growth of the plant. [...]

18 April 2024|

HAS Healthcare Advanced Synthesis SA achieves Carbon Neutrality

Biasca, Switzerland, March 23, 2023 – HAS Healthcare Advanced Synthesis, one of the leading development and manufacturing companies in the international chemical-pharmaceutical industry, delivering for years active pharmaceutical ingredients (APIs), high-activity active pharmaceutical ingredients (HPAPIs) and anticancer compounds for pharmaceutical and biotechnology companies, today announces that it has achieved carbon neutrality for the year 2021. This [...]

27 March 2023|

Helsinn Group has announced that it has achieved carbon neutrality for the first time.

Lugano, Switzerland, December 6, 2021 – Helsinn Group (“Helsinn”), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets and strong track-record of commercial execution, today announces that it has achieved carbon neutrality for the first time. Since 2012, Helsinn has been committed to becoming more sustainable. Our environmental performance has improved steadily [...]

7 December 2021|